Reinstatement to Quotation
Open PDF
| Stock | Pharmx Technologies Ltd (PHX.ASX) |
|---|---|
| Release Time | 11 Jul 2025, 4:59 p.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Pharmx Technologies reinstated to ASX quotation
Key Points
- Pharmx Technologies' trading suspension lifted after announcement on NDSS agreement renewal
- Company to resume trading on the ASX immediately
- NDSS agreement renewal secures ongoing revenue stream
Full Summary
Pharmx Technologies Ltd (ASX: PHX) has been reinstated to trading on the Australian Securities Exchange (ASX) following the release of an announcement regarding the renewal of its long-standing National Diabetes Services Scheme (NDSS) agreement. The suspension of trading in Pharmx's securities has been lifted immediately, allowing the company to resume trading on the ASX. The NDSS agreement renewal secures an ongoing revenue stream for Pharmx, which is a key component of the company's business operations. This announcement provides investors with confidence in Pharmx's financial stability and future prospects as it continues to serve the diabetes care market through its products and services.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In